218 related articles for article (PubMed ID: 2959866)
1. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase.
Gruters RA; Neefjes JJ; Tersmette M; de Goede RE; Tulp A; Huisman HG; Miedema F; Ploegh HL
Nature; 1987 Nov 5-11; 330(6143):74-7. PubMed ID: 2959866
[TBL] [Abstract][Full Text] [Related]
2. Recombinant HIV envelope expressed in an alpha-glucosidase I-deficient CHO cell line and its parental cell line in the presence of 1-deoxynojirimycin is functional.
Fenouillet E; Papandréou MJ; Jones IM
Virology; 1997 Apr; 231(1):89-95. PubMed ID: 9143306
[TBL] [Abstract][Full Text] [Related]
3. Effects of inhibitors of glycoprotein processing on oligodendroglial differentiation in primary cultures of embryonic rat brain cells.
Bhat NR
J Neurosci Res; 1988; 20(2):158-64. PubMed ID: 2971819
[TBL] [Abstract][Full Text] [Related]
4. Processing and secretion of envelope glycoproteins of human immunodeficiency virus type 1 in the presence of trimming glucosidase inhibitor deoxynojirimycin.
Pal R; Kalyanaraman VS; Hoke GM; Sarngadharan MG
Intervirology; 1989; 30(1):27-35. PubMed ID: 2542177
[TBL] [Abstract][Full Text] [Related]
5. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein.
Fenouillet E; Gluckman JC
J Gen Virol; 1991 Aug; 72 ( Pt 8)():1919-26. PubMed ID: 1678778
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus induces phosphorylation of its cell surface receptor.
Fields AP; Bednarik DP; Hess A; May WS
Nature; 1988 May; 333(6170):278-80. PubMed ID: 3259291
[TBL] [Abstract][Full Text] [Related]
7. Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.
Pal R; Hoke GM; Sarngadharan MG
Proc Natl Acad Sci U S A; 1989 May; 86(9):3384-8. PubMed ID: 2541446
[TBL] [Abstract][Full Text] [Related]
8. Castanospermine and other plant alkaloid inhibitors of glucosidase activity block the growth of HIV.
Tyms AS; Berrie EM; Ryder TA; Nash RJ; Hegarty MP; Taylor DL; Mobberley MA; Davis JM; Bell EA; Jeffries DJ
Lancet; 1987 Oct; 2(8566):1025-6. PubMed ID: 2889932
[No Abstract] [Full Text] [Related]
9. Antiviral effects of glycosylation and glucose trimming inhibitors on human parainfluenza virus type 3.
Tanaka Y; Kato J; Kohara M; Galinski MS
Antiviral Res; 2006 Oct; 72(1):1-9. PubMed ID: 16730076
[TBL] [Abstract][Full Text] [Related]
10. Effects of tunicamycin and N-linked oligosaccharide-processing inhibitors on the morphology of cultured porcine thyroid cells.
Giraud A; Franc JL
Eur J Cell Biol; 1989 Feb; 48(1):128-34. PubMed ID: 2526017
[TBL] [Abstract][Full Text] [Related]
11. Glucosidase trimming inhibitors preferentially perturb T cell activation induced by CD2 mAb.
van Kemenade FJ; Rotteveel FT; van den Broek LA; Baars PA; van Lier RA; Miedema F
J Leukoc Biol; 1994 Aug; 56(2):159-65. PubMed ID: 7915296
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine.
Walker BD; Kowalski M; Goh WC; Kozarsky K; Krieger M; Rosen C; Rohrschneider L; Haseltine WA; Sodroski J
Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8120-4. PubMed ID: 2825177
[TBL] [Abstract][Full Text] [Related]
13. Different effects of the glucosidase inhibitors 1-deoxynojirimycin, N-methyl-1-deoxynojirimycin and castanospermine on the glycosylation of rat alpha 1-proteinase inhibitor and alpha 1-acid glycoprotein.
Gross V; Tran-Thi TA; Schwarz RT; Elbein AD; Decker K; Heinrich PC
Biochem J; 1986 Jun; 236(3):853-60. PubMed ID: 2947571
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
Lazar C; Durantel D; Macovei A; Zitzmann N; Zoulim F; Dwek RA; Branza-Nichita N
Antiviral Res; 2007 Oct; 76(1):30-7. PubMed ID: 17548120
[TBL] [Abstract][Full Text] [Related]
15. Effect of glycoprotein-processing inhibitors on the mouse IgE binding capacity of rat basophilic leukemia cells.
Gavériaux C; Loor F
Int Arch Allergy Appl Immunol; 1987; 84(1):85-92. PubMed ID: 2957325
[TBL] [Abstract][Full Text] [Related]
16. Effects of deoxymannojirimycin and castanospermine on the polarized secretion of thyroglobulin.
Franc JL; Giraud A; Lanet J
Endocrinology; 1990 Mar; 126(3):1464-70. PubMed ID: 2137773
[TBL] [Abstract][Full Text] [Related]
17. Neuraminidase from a bacterial source enhances both HIV-1-mediated syncytium formation and the virus binding/entry process.
Sun J; Barbeau B; Sato S; Tremblay MJ
Virology; 2001 May; 284(1):26-36. PubMed ID: 11352665
[TBL] [Abstract][Full Text] [Related]
18. Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1.
Montefiori DC; Robinson WE; Mitchell WM
Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9248-52. PubMed ID: 3264072
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of yeast exoglucanases by glucosidase inhibitors.
Ridruejo JC; Muñoz MD; Andaluz E; Larriba G
Biochim Biophys Acta; 1989 Dec; 993(2-3):179-85. PubMed ID: 2532041
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Düzgünes N
Biochem Biophys Res Commun; 1995 Mar; 208(1):75-81. PubMed ID: 7887968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
